Exercise is Medicine: Immunology, Cancer and the Exercise Rx
Prices per Course | NOTE: ACLM members receive an exclusive 20% discount.
Nonmember - $75
Member - $60
1.5 CME/CNE/CE Credits
1.5 CPE Credits
(Full Accreditation information listed below)
Exercise really is medicine! It's one thing to tell your patient to exercise more, but it's quite another to understand the immense breadth and depth of what is known in the exercise sciences. Exercise is well known to treat cardiac and metabolic disorders, but exercise scientists increasingly study how exercise can also modulate immune function which is a pressing need in current times. Exercise also factors as a key modality in primary and recurrent cancer treatments. These three presenters, all national experts in their respective disciplines, will take the audience through a tour of basic exercise science and clinical outcomes as applied to immune function and cancer treatments and finalize by showing you how to provide effective and targeted exercise prescriptions to your lifestyle medicine intervention toolkit.
- Explain the impact of physical activity in terms of prevention of disease, reduction in mortality rates, positive effects in the elderly and kids, and exercise as a clinical intervention for disease.
- Outline the key components for exercise assessment and prescription in a clinical setting, including using an Exercise Vital Sign.
- Describe the Exercise Is Medicine Global Health initiative and how it is related to health and disease.
Cate Collings, MD, FACC, MS, DipABLM – Medical Director, Lifestyle Medicine, El Camino Medical Associates, Silicon Valley Medical Development
Dr. Collings is board certified in both Cardiology and Lifestyle Medicine. She is currently director of Lifestyle Medicine at Silicon Valley Medical Development and medical director of Cardiopulmonary Wellness at El Camino Health in the San Francisco Bay Area. Dr. Collings also is president-elect of the American College of Lifestyle Medicine, which is a medical professional society recognizing that just as lifestyle is the primary driver of our chronic disease epidemic, providing evidence-based lifestyle solutions is the most effective way to achieve high quality and value-based care. Dr. Collings has over 30 years of clinical experience in Cardiology, Cardiopulmonary Rehabilitation, and Lifestyle Medicine and is an ardent patient advocate In her capacity as Director of Lifestyle Medicine for Silicon Valley Medical Development, she is building Lifestyle Medicine into the fabric of a new primary care model as a means of further focusing on the quadruple aim in her medical community and the broader Bay Area. She believes the use of teaching kitchens, selective use of digital technologies, and approaching clinical encounters through a coaching mindset are key elements to successfully transition patients to a healthy lifestyle. In service to ACLM, Dr. Collings has chaired the Education Committee, bringing education to practicing physicians and into medical, residency, and fellowship curriculum, and co-authored ACLM Standards. She also has participated in the Lifestyle Medicine in Health Systems Task Force, among other roles.
Kathryn H. Schmitz, PhD, MPH – Professor, Penn State
Professor, Department of Public Health Sciences Division of Health Services and Behavioral Research Professor, Department of Physical Medicine and Rehabilitation Dr. Kathryn Schmitz is a leading researcher in exercise oncology - the use of exercise in cancer prevention, control and survivorship. Dr. Schmitz, who has led many exercise trials and translated her work into clinical practice, has published more than 240 peer-reviewed scientific papers and has had $25 million in funding for her research since 2001. She was the lead author of the first American College of Sports Medicine (ACSM) Roundtable on Exercise for Cancer Survivors, which published guidance for exercise testing and prescription for cancer survivors in July 2010. In March 2018, Dr. Schmitz chaired an International Multidisciplinary ACSM Roundtable on Exercise and Cancer Prevention and Control, at which physicians, outpatient rehabilitation specialists, researchers and exercise professionals in the room broadly agreed that the field of exercise oncology needs to be elevated further. Dr. Schmitz’s professional mission is to determine how to do so.
Richard J. Simpson, PhD, FACSM – Associate Professor, University of Arizona
Associate Professor, Department of Nutritional Sciences Chair, Graduate Research Degrees in Nutritional Sciences Associate Professor, Steele Children's Research Center, Dept. of Pediatrics, College of Medicine Dr. Simpson completed his training in exercise physiology and immunology at Edinburgh Napier University in Scotland before spending nine years as a faculty member at the University of Houston. He studies the effects of exercise and stress on the immune system. Major cross-cutting themes of his work are aging (immunosenescence), cancer and spaceflight. Specifically, Dr Simpson and his team study how single exercise bouts can be used to augment the recovery and expansion of specific immune cells that can be used therapeutically to treat patients with hematologic malignancies; and how exercise can be used to negate the onset of immunosenescence during natural aging. He is also interested in how exercise training can contribute to improved patient survival and quality of life through immune and inflammatory pathways at all phases of the cancer care continuum. His current work includes four NASA funded projects that aim to examine the impact of long duration spaceflight and extreme isolation on astronaut immune function and illness rates, and the effects of simulated microgravity on viral infectivity and host immune evasion. Dr. Simpson is also investigating how certain viral infections can protect patients from relapse following hematopoietic stem cell transplantation in a project that has been funded by the National Cancer Institute. Dr. Simpson is a Fellow of the American College of Sports Medicine (ACSM), a member of the Psycheneuroimmunology Research Society (PNIRS), and an honorary board member of the International Society of Exercise and Immunology (ISEI). He is Associate Editor of the ISEI journal Exercise Immunology Reviews, and is on the editorial board of the journals Brain, Behavior and Immunity, Inflammopharmacology and American Journal of Lifestyle Medicine.
Bob Sallis, MD, FAAFP, FACSM – Co-Director; Sports Medicine Fellowship, Kaiser Permanente Medical Center; Fontana, CA
Dr. Sallis is a family medicine physician practicing at Kaiser Permanente Medical Center in Fontana, California, where he serves as Co-Director of their Sports Medicine Fellowship program. He is a Clinical Professor of Family Medicine at the University of California, Riverside (UCR) School of Medicine. He is a Past-President of the American College of Sports Medicine (ACSM) and currently chairs Exercise is Medicine™, a joint initiative of ACSM and the American Medical Association. He also chaired the Healthcare Sector for the U.S. Physical Activity Plan. Dr. Sallis received his Bachelor of Science degree from the U.S. Air Force Academy (where he played intercollegiate basketball) and his Medical Degree from Texas A&M University. He completed his residency in Family Medicine at Kaiser Permanente Medical Center in Fontana, CA, where he served as chief resident. He is also the head team physician for the Los Angeles Football Club and Chairs the Ironman Sports Medicine Conference in Kona, Hawaii. He is Board Certified in Family Medicine and holds a Certificate of Added Qualifications in Sports Medicine.
LM2020 OnDemand sessions are hosted online via the ACLM Learning Management System and each session consists of a title, description, learning objectives, speaker information, video recording, presentation slides in PDF format, an assessment and survey evaluation.
This content can be viewed on a desktop, tablet or mobile device. Speakers or headphones are required.
Term of Approval
February 22, 2021 – February 22, 2023
Access to course: access to online material is granted through the term of approval which ends February 22, 2023.
In support of patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.
Rush University Medical Center designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ANCC Credit Designation – Nurses The maximum number of hours awarded for this CE activity is 1.5 contact hours. This activity is being presented without bias and without commercial support.
Rush University Medical Center designates this knowledge based CPE activity for 1.5 contact hours for pharmacists.
Rush University is an approved provider for physical therapy (216.000272), occupational therapy, respiratory therapy, social work (159.001203), nutrition, speech-audiology, and psychology by the Illinois Department of Professional Regulation. Rush University designates this live activity for 1.5 Continuing Education credits.
The Commission on Dietetic Registration accepts self-study programs approved through the ACCME.
The American Board of Lifestyle Medicine has approved 1.5 maintenance of certification credits for this learning activity.
AAFP Prescribed Credits
The AAFP has reviewed LM2020 OnDemand: Health Restored Virtual Conference, and deemed it acceptable for AAFP credit. Term of approval is from 02/23/2022 to 02/23/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session: 1.50 Enduring Materials, Self-Study AAFP Prescribed Credit(s) - Exercise is Medicine: Immunology, Cancer and the Exercise Rx
It is the policy of the Rush University Office of Interprofessional continuing Education to ensure that its CE activities are independent, free of commercial bias and beyond the control of persons or organizations with an economic interest in influencing the content of CE. Everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest (including but not limited to pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic) within the preceding 12 months.
Unapproved Uses of Drugs/Devices: In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.
The course directors, planners and faculty of this activity have stated they have no relevant financial disclosures.